Breaking News

Adare Expands High Potency Handling Capabilities in the U.S. and Europe

Announces facility expansions in Philadelphia, Vandalia and Milan.

Author Image

By: Charlie Sternberg

Associate Editor

Adare Pharma Solutions, a CDMO specializing in oral dosage forms, is expanding its high potency handling capabilities in the United States and Europe. ​ In the United States, a second high potency suite is being added to Adare’s 128,000 sq ft (12,000 sq m) Orthodox Street facility in Philadelphia, which will provide encapsulation, high-shear granulation, blending, and other manufacturing processes. Construction of the new suite will be completed by Q4 of 2024 and will complement the site’s exi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters